Introduction
Falls can cause serious injuries, disabilities and might even lead to death, in particular in case of elderly persons. About ͵Ͳ percent of the community-dwelling people aged ͷ years or older experience at least one fall every year. People being older than eighty years even fall with a probability of ͷͲ percent per year. The injuries resulting from falls often require extensive medical treatment and -let alone the threat to quality of life of the persons concernedrepresent a non-negligible economic factor as these injuries often entail long and expensive rehabilitation periods. 1 Against this background, the influence of FRIDs on falls or fall-related injuries of elderly persons has been examined extensively throughout the last decades. Meta-analyses and reviews ʹǡ͵ reveal that the literature focuses almost exclusively on injuries of certain body regions, such as hip fractures Ͷ , or on certain drugs ͷ-7 such as psychotropic agents. Furthermore, existing studies predominantly rely on cohort and case-control designs. Both designs should be considered with caution, as they often suffer from a lack of validity due to sample selection bias. ͺ Only a few studies are bas ͻ or representative cross-sectional data, ͳͲ mainly because of a lack of appropriate data. Furthermore, most existing studies rely on data for the US and Canada. ǡͳͳǡͳʹ Only one study investigates the effects of FRIDs using German data. 13 Finally, existing empirical studies predominantly apply logistic regressions ͳʹǡͳͶ or Cox proportional . Ͷ Despite these differences in the data and empirical methods used, most studies conclude that it is inevitable to be cautious when prescribing drugs to the elderly, as they can increase the risk of injuries. ͳǡͳʹǡͳͶǡͳͷ In particular the following pharmaceuticals are classified as fall-risk increasing drugs (FRIDs): anxiolytics, hypnotics, sedatives, antidepressants, neuroleptics, analgetics, antihypertensives, antiarrhythmics and antiparkinsonian agents as well as drugs from the Beers criteria medication list describing potentially inappropriate medication consumption of older adults. ǡͳ Howevǡ these results and stating that there are other factors causing fall-related injuries such as morbidity or diseases that were not considered in the analyses. After controlling for these factors, hardly any significant increase in fall risk due to drug consumption can be stated. 11
Using routine data from a German statutory health insurance fund, this study investigates the specific risk of injuries due to the prescription of FRIDs in older ages. We estimate the influence of FRIDs on the number of injuries using a count data model. This regression model takes the specific data generating process of our dependent variable (the number of fall-related injuries) into account, which results in a non-negative variable with integer values, and hence avoids several limitations of the widely used logistic regression approach.
Methods

Data
The empirical analysis is based on data ʹͲͲͻ from the Techniker Krankenkasse (TK) 
Injuries
As dependent variable we employ injuries and fractures of all body parts, i.e., injuries with the ͲͲ-ͻͺ ȋ -ͳͲȌǤ ǡ ʹǤͷͳ ʹͲͲͻǤ ͳ ͷ͵ frail elderly experienced at least one injury in the considered period of time. Even though the maximum number of recorded injuries is Ͳ, ͳ ͳͷ ͳͷ . As the majority of injuries, such as fractures and soft-* In Germany, the long-term care insurances which are part of the health insurances distinguish between three care levels with increasing severity of care which are formally assessed by an independent Medical Review Board of the Statutory Health Insurance Funds.
tissue injuries of the elderly are related to falls, the number of recorded injuries can also be considered as a proxy for falls. ͳͷ 
Fall Risk Increasing Drugs (FRIDs)
As potentially FRIDs we consider the annual sums of prescribed daily defined doses (DDDs), an internationally comparable statistical unit of measurement for drug consumption. ͳͺ The sums of DDDs are calculated for the following drugs from the Anatomical Therapeutic Chemical (ATC)
classification:
x A ȋ ǣ Ͳ Ȍǡ 
Logistic regression vs. count data models
In order to assess the effect of FRIDs on injuries in a multivariate setting, we apply two types of regression models: (i) a logistic regression, where the dependent variable takes the value "1" if ʹͲͲͻǡ ǲͲǳ otherwise; and (ii) a count data model, where the dependent variable represents ʹͲͲͻ. In both models, we control for a set of variables describing the drugs prescribed to an individual and a set of variables describing the disease patterns, socio-economic characteristics as well as care dependency of the insurants.
In the existing literature, the use of specific drugs enters the regression models predominantly as dichotomous variables. In addition to this type specification, we also provide estimation results for regression models in which the use of specific drugs is measured in DDDs. As the drugs from the Priscus-list are part of the other drug categories used in our models, we perform the estimations for the Priscus-list separately.
Most existing studies in the relevant literature rely on logistic regressions for dichotomous dependent variables in order to investigate the fall risk increasing effects of certain drugs. ͳʹǡͳͶ
This type of regression model only allows estimating the probability that one or more injuries 
Results
We use our estimated results from the Logit and Zero Inflated NegBin models to predict the number and the probability of injuries for elderly with and without any prescriptions of FRIDs.
In the model with drugs measured in DDDs we use the mean number of DDDs of consumers of the certain drugs to predict the number of injuries for people who take these drugs ‡ . To demonstrate the quantitative effects of taking FRIDs, we calculate the percentage difference of the predicted number of injuries between consumers and non-consumers of a particular drug non-consumers § . The effects estimated by using the Logit model show the increase of the probability of suffering from injuries when taking the considered drugs compared to not taking FRIDs. R ‡ ǣ ǣ ʹͺ͵ǤʹͲǢ ǣ ͻͶǤͻǢ ǣ ͳͷͺǤʹͳǢ ǣ ͻͷǤͲǢ ǣ ͵͵ǤʹǢ ǣ ʹͶǤͻͺǢ ǣ ͳͳʹǤͻͲǢ Priscus-listǣ ͳͻͺǤͺǤ § If I መ denotes the predicted number of injuries for consumers of drug ݅ and I መ ே those of non-consumers, Table 3 shows ‫ܫܦ‬ = The results shown in Table 3 reveal that not all drugs under consideration increase the risk of injuries. In our benchmark model, we find no significant effects for antihypertensives and antiparkinsonian agents, while neuroleptics even appear to have a significant negative effect on injuries. Significant positive effects on injuries are found for antidepressants, anxiolytics, hypnotics and sedatives, antiarrhythmics as well as the drugs from the Priscus-list. In all models, the highest effects are obtained for antiarrhythmics. According to the results from the Logit model, the prescription of this drug increases the risk of experiencing at least one injury on ͵ͳǤ͵ͷΨǤ The results from the Zero Inflated NegBin model show that the frequency of ʹͳǤͷΨ consumers of antiarrhythmics ** .
Discussion
The contribution of our study to existing literature is manifold. First, drugs from the recently published Priscus-list these drugs before. Secondly, the empirical analysis is based on routine data ʹͲ,ͲͲͲ observations, which allows more precise estimates for the effects of FRIDs on injuries than most other previous studies. Thirdly, we are able to control for many confounding factors and ** The results refer to people who take the average prescribed amount of DDDs of the considered drug under the condition that they take the drug at all. variables such as various diseases and the care dependency level of individuals, which are neglected by some recent studies. ͷǡͳͶ Fourthly, for the first time we rely on a count data model to estimate the influence of FRIDs on injuries. In contrast to previously used models the count data model explicitly allows to take the number of injuries into account. ǡ that the exploration of the influence of FRIDs on falls and fall-related injuries does not consider dosages. ʹ We are able to overcome this shortcoming as our data provide information on DDDs.
Despite these advantages, there are also impairments in our study. We are only able to measure drug prescriptions instead of factual drug use. Note however, such a measurement error usually results in an attenuation bias. Hence, if anything we estimate a lower bound of the injury-risk increasing effects of FRIDs. Based on the available data it cannot be detected if the patient took the drugs before or after an injury. In addition, we are not able to determine the circumstances of an injury. Although, most of the injuries of elderly persons are fall-related, ͳ this fact could lead to an overestimate of the actual effect of the considered drugs on injuries, as some of the included injuries may arise from external causes others than falls.
Even thought there is a growing literature on models specifically developed for count data, only few studies in epidemiology and public health exploit the advantages of these approaches to model health outcomes, such as injuries. ʹ͵ This study shows that when dealing with injuries caused by FRIDs, the use of count data models is recommended rather than relying on dichotomous regression models. In the present application, models specifically developed for of certain drugs.
